期刊文献+

屈螺酮中间体的合成工艺改进

An Improved Method for Synthesis of Intermediate of Drospirenone
下载PDF
导出
摘要 以7α溴-5,6β-环氧-15β,16β-亚甲基-3β-新戊酰氯氧基-5β-雄甾烷-17-酮为原料,经过磺酰化、溴代、开环脱溴等步骤制得屈螺酮关键中间体5-羟基-15β,16β-亚甲基-3β-新戊酰氧基-5β-雄甾-6-烯-17-酮的方法。优化了合成路线中的磺酰化、溴代、开环脱溴等反应条件。结果表明,优化后的总收率可达66.8%。该方法操作简单,且产物结构经^(1)HNMR、^(13)CNMR、ESI-MS等检测方法确证。 This paper introduced a method for synthesis of 5-hydroxy-15β,16β-methylene-3β-pivaloyloxy-5β-androst-6-en-17-one,the key intermediate of drospirenone,with the starting material of 5,6β-epoxy-7β-hydroxy-15β,16β-methylene-3β-pivaloyloxy-5β-androst-17-one being introduced via process of sulfonylation,bromination,ring opening and debromination.The reaction conditions of sulfonylation,bromination,ring opening and debromination were optimized,and the total yield was increased to 66.8%.The method was simple to operate and the structure of the product was confirmed by ^(1)HNMR,^(13)CNMR and ESI-MS.
作者 叶有志 潘建洪 隋志红 金旦妮 YE Youzhi;PAN Jianhong;SUI Zhihong;JIN Danni(Taizhou Xianju pharmaceutical CO.,Ltd,Taizhou,Zhejiang 317016)
出处 《化工生产与技术》 CAS 2021年第5期4-6,14,I0001,共5页 Chemical Production and Technology
关键词 5-羟基-15β 16β-亚甲基-3β-新戊酰氧基-5β-雄甾-6-烯-17-酮 屈螺酮 溴代 磺酰化 5-hydroxy-15β,16β-methylene-3β-pivaloyloxy-5β-androst-6-en-17-one drospirenone bromination p-tosyl chloride
  • 相关文献

参考文献5

二级参考文献102

  • 1陈丽刚,熊承良,官黄涛.两种单向复方口服避孕药对经前期综合征影响的研究[J].中国妇幼保健,2007,22(6):788-790. 被引量:9
  • 2Rible RD, Taylor D, Wilson ML, et al. Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mg ethinyl estradiol and 1 mg norethindrone acetate. Contraception, 2009, 79(3): 182-8.
  • 3The ESHRE Capri Workshop Group. Noncontraceptive health benefits of combined oral contraception.Hum Reprod Update, 2005, 11(5):513-25.
  • 4Eriksson E, Sundblad C, Lisjo P, et al. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls.Psychoneuroendocrinology, 1992, 17(2-3): 195-204.
  • 5Brien O, Craven D, Selby C, et al. Treatment of premenstrual syndrome by spironolactone. Br J Obstet Gynaecol, 1979, 86 (2):141-7.
  • 6Hahn PM, van Vugt DA, Reid RL. A randomized, placebocontrolled, crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinology, 1995, 20(2): 193-209.
  • 7Brown CS, Ling FW, Andersen RN, et al. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Obstet Gynecol, 1994, 84(5):779-86.
  • 8Schmidt PJ, Nieman LK, Danaceau MA, et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med,1998, 338(4):209-16.
  • 9Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res,1992, 36(3):257-66.
  • 10Yonkers KA, Brown C, Pearlstein TB, et al. Efficacy of a new low-dose oral contraceptive with drospirenone in premestrual dysphoric disorder. Obstet Gynecol, 2005, 106(3):492- 501.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部